UK Clinical Trials Gateway (UKCTG)

Welcome

12 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN

mRCT

Information

DUETS

DISCLAIMER

The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION

Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

UK trials

Showing records: 31 to 40 of 3810

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS	.

31	A Multicentre Randomised and Comparative Trial to Assess the Tolerance, Efficacy and Pharmacokinetics of Escalating Doses of Casodex Versus Castration in the Treatment of Advanced Carcinoma of the Prostate
	ISRCTN:	ISRCTN16559899
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

32	A Multicentre, Double-Blind, Randomised, Parallel Group, Placebo-Controlled Trial of LAX-101 (ethyl eicosapentaenoate [EPA]) as Adjunct Therapy in Patients Who Remain Depressed Following Treatment with Standard Antidepressant Therapy
	ISRCTN:	ISRCTN38354847
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

33	A Multicentre, Double-Blind, Randomised, Parallel Group, Placebo-Controlled Trial of LAX-101 (ethyl eicosapentaenoate [EPA]) in Patients with a New or Recurrent Episode of Depression
	ISRCTN:	ISRCTN63565713
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

34	A Multicentre, Multinational, Double Blind, Randomised, Parallel Group, Placebo-Controlled Study of Ethyl-Eicosapentaenoate (EPA) in Patients with Huntington's Disease (HD)
	ISRCTN:	ISRCTN79170611
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

35	A Multicentre, Randomised, Double Blind, Placebo Controlled, Multiple Ascending Dose, Safety, Tolerability, And Amyloid-Imaging Positron Emission Tomography (PET) Trial Of AAB 001 (ELN115727) In Patients With Mild To Moderate Alzheimer's Disease (AD)
	ISRCTN:	ISRCTN17517446
	Status:	Ongoing
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

36	A Phase II Randomised Study of Cisplatinum and Nifedipine in End Stage Carcinoma of the Head and Neck
	ISRCTN:	ISRCTN76747656
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

37	A Phase II Randomised Study of the Addition of Methotrexate 0.05 mg/kg 12 hourly for 8 doses to the Current Immunosuppressant Regimen for the Prevention of Liver Allograft Rejection.
	ISRCTN:	ISRCTN58758525
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

38	A Phase II study to evaluate the efficacy and safety of PTK787 in patients with metastatic cutaneous melanoma
	ISRCTN:	ISRCTN00191981
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

39	A Phase III Randomised comparison of Gemcitabine/Carboplatin with Cisplatin/Etoposide in Small Cell Lung Cancer
	ISRCTN:	ISRCTN39679215
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

40	A Phase III randomised comparison of Gemcitabine/Carboplatin with Mitomycin, Ifosfamide and Cisplatin in non-small cell lung cancer
	ISRCTN:	ISRCTN52253218
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

RESULT PAGE


© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. \| terms & conditions \| privacy statement